Trial Details
TERMINATEDBasic Information
| Clinical ID | c1641 |
|---|---|
| Identifier | NCT03616821 |
| Trial Title | Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|IBD |
| Interventions | DRUG: Brazikumab|DRUG: Placebo |
Participant Information
| Sponsor | AstraZeneca |
|---|---|
| City | Phoenix |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2018-08-07 |
|---|---|
| Primary Completion Date | 2023-10-23 |
| Completion Date | 2023-10-23 |